India breast oncology cost guide

Breast cancer treatment cost in India by stage, subtype and sequence

Breast cancer cost depends on more than the operation. Clinical stage, tumor grade, ER and PR receptors, HER2, lymph nodes, menopause, inherited risk, response to preoperative therapy, reconstruction preference, and the need for radiation or long-term medicines determine the complete pathway.

What does breast cancer treatment cost in India?

A practical 2026 range is about INR 4,00,000 to INR 30,00,000+ (approximately USD 4,200 to USD 31,200+). Surgery-led early disease may remain in the lower bands. Reconstruction, multi-cycle chemotherapy, radiation, HER2-targeted medicines, immunotherapy, or metastatic treatment can raise cost substantially and may continue for months or years.

USD figures use approximately INR 96.22 per USD from the RBI display on July 15, 2026 and are rounded for planning. INR billing, body-size drug dosing, brand, exchange rate, and treatment duration change the paid amount.

Review cost scenarios Upload reports

Let Us Help You

Share the basics and the Virello team will guide you toward the next step.

Prefer email? Write to support@virellohealth.com.

Patient Name

Country

Phone Number

Describe The Current Medical Problem

Reviewed 2026-07-18

Clinical review: Virello Health Clinical Review Team · Editorial review: Virello Health Medical Travel Editorial Team

Billing context: INR and USD

Decisive reports

Core biopsy, histologic type and grade, ER, PR, HER2, Ki-67, breast and axillary imaging, and current staging evidence.

Sequence varies

Some early cancers begin with surgery; selected larger, node-positive, HER2-positive, or triple-negative cancers may start with systemic therapy.

Function matters

Breast conservation, reconstruction, lymphoedema risk, fertility, menopause, bone health, and sexual wellbeing belong in the plan.

Long-term budget

Hormone and targeted treatment may continue after travel, so home-country supply and monitoring must be priced before starting.

Cost at a glance

Planning scenarios for breast cancer treatment in India

The scenarios separate routine and complex pathways. They are not fixed packages and should be replaced by a report-led hospital estimate before travel.

Estimated breast cancer treatment cost scenarios in India
Scenario	INR	USD	Patient and treatment context	Planning scope
Early surgery-led pathway	INR 4,00,000-8,00,000	USD 4,200-8,300	DCIS or selected stage I-II disease proceeding to lumpectomy or mastectomy with node assessment and no immediate major reconstruction.	Breast operation, routine pathology, standard admission, and early follow-up; radiation and systemic therapy are separate unless named.
Combined curative-intent pathway	INR 8,00,000-18,00,000	USD 8,300-18,700	Disease requiring chemotherapy before or after surgery, breast or chest-wall radiation, node treatment, or a defined reconstruction.	Budget every operation, drug cycle, radiation course, pathology checkpoint, supportive item, and local-stay phase.
HER2-positive, triple-negative, or advanced pathway	INR 15,00,000-30,00,000+	USD 15,600-31,200+	Prolonged HER2-directed therapy, checkpoint inhibitor when indicated, complex reconstruction, metastatic treatment, or repeated response imaging.	Medicine dose, brand, duration, maintenance, complications, and later lines can push the total above this planning band.

Usually included

Check the clinical package scope

Breast-team review

Breast surgeon, medical and radiation oncology, radiology, pathology, and reconstruction input as needed.

Ask whether a documented tumor board occurs.

Named local-treatment phase

Lumpectomy, mastectomy, sentinel node biopsy, axillary surgery, radiation course, or described reconstruction.

Require side, node, and implant or flap scope.

Specified systemic cycle

Named chemotherapy, targeted, immune, or hormone medicine at the assumed dose and schedule.

Confirm brand, vials, and supportive drugs.

Routine facility care

Theatre or day care, anesthesia, nursing, monitoring, room and standard consumables within limits.

Record admission and room assumptions.

Standard early follow-up

Wound or cycle review, pathology discussion, prescriptions, warning signs, and next-phase plan.

Later scans are often separate.

Confirm separately

Charges that may sit outside the range

Pathology refinement

Outside review, repeat HER2 testing, genomic recurrence assay, germline testing, or another biopsy.

Only order tests that answer a treatment question.

Reconstruction beyond stated scope

Implant, expander, mesh, flap, microsurgery, opposite-breast procedure, nipple reconstruction, tattooing, or revision.

Cancer and reconstruction estimates should be separate.

Later therapy phases

Chemotherapy, radiation, HER2 treatment, immunotherapy, hormone treatment, bone medicine, or maintenance not named.

Ask for the entire anticipated sequence.

Fertility and survivorship services

Egg or embryo preservation, ovarian suppression, lymphoedema garment, physiotherapy, menopause, sexual-health, or psychosocial care.

Discuss before time-sensitive treatment.

Complication treatment

Infection, seroma, flap or implant problem, neutropenic fever, thrombosis, organ toxicity, readmission, or re-operation.

Maintain a separate reserve.

Candidate context

Who may be considered and what else may be discussed

The treating team combines clinical and pathologic stage with tumor biology and patient priorities. A lumpectomy quote is not meaningful until margin feasibility and radiation access are considered; a mastectomy quote is incomplete without node and reconstruction decisions; a drug quote is incomplete without receptor results, dose, cycles, and response checkpoints.

Information that shapes suitability

Pathology and biomarkers verified

Histology, grade, ER, PR, HER2 and relevant additional tests are reviewed on adequate tissue.

Local extent mapped

Breast and axillary imaging assess size, multifocal disease, nodes, skin or chest involvement, and conservation feasibility.

Systemic stage assessed appropriately

Symptoms, clinical stage, and risk determine whether broader imaging is needed before treatment.

Patient priorities documented

Breast preservation, reconstruction, fertility, pregnancy, menopause, hereditary risk, function, work, and follow-up access affect choices.

Alternatives or sequencing questions

Lumpectomy plus radiation

Breast-conserving surgery commonly requires clear margins and appropriate postoperative radiation planning.

Mastectomy with or without reconstruction

Extent, radiation likelihood, medical fitness, smoking, diabetes, preference, and reconstructive expertise shape timing.

Preoperative systemic therapy

Chemotherapy, HER2-targeted treatment, or immunotherapy may be used first for selected biology and stage, with response informing surgery.

Endocrine or palliative systemic care

Hormone-sensitive or metastatic disease may prioritize medicines, symptom control, bone care, or focused radiation rather than immediate breast surgery.

Procedure variations

Why the named procedure does not have one price

Technique, device, medicine, treatment extent, and prior care can change both the clinical plan and the estimate.

Lumpectomy and sentinel node

Removes the breast lesion with margin assessment and samples first-draining nodes when indicated.

Re-excision and radiation can add cost.

Mastectomy and axillary pathway

Simple, skin-sparing, nipple-sparing, or modified radical surgery differs in tissue and node extent.

Not every technique suits every tumor.

Implant or autologous reconstruction

Immediate or delayed implant, expander, local flap, or free flap has different teams, theatre time, risk, and revisions.

Radiation timing can change the strategy.

Subtype-led systemic treatment

Hormone-sensitive, HER2-positive, triple-negative, and hereditary-associated disease use different drugs and durations.

Compare exact protocols, not “breast chemo.”

City comparison

Cost and capability by city in India

Only cities with evidence for the procedure should appear here. A city range does not prove that every hospital in that city can manage the same case complexity.

Estimated breast cancer treatment costs and planning context by city in India
City	Local range	USD range	Capability context	Stay planning
Mumbai	INR 5,50,000-30,00,000+	USD 5,700-31,200+	Selected centers offer breast units, oncoplastic and microsurgical reconstruction, advanced radiation, systemic therapy, and genetics.	Separate public or charitable access from private pricing and waiting time.
Delhi NCR and Gurugram	INR 5,50,000-29,00,000+	USD 5,700-30,100+	Broad private multidisciplinary, robotic or oncoplastic, radiation, and drug pathways.	Compare reconstruction and accommodation across campuses.
Bengaluru	INR 5,00,000-27,00,000+	USD 5,200-28,100+	Strong breast imaging, pathology, surgery, medical oncology, radiation, and survivorship at selected programs.	Confirm all phases and drug supply on one pathway.
Chennai	INR 4,80,000-25,00,000+	USD 5,000-26,000+	Established oncology networks manage breast surgery, chemotherapy, radiation, and reconstruction.	Model weeks of radiation or repeat infusions.
Hyderabad	INR 4,80,000-24,00,000+	USD 5,000-24,900+	Selected centers integrate pathology, surgical oncology, day care, radiation, and critical support.	Verify genomic-test and targeted-drug turnaround.
Kolkata	INR 4,40,000-22,00,000+	USD 4,600-22,900+	Regional referral programs offer comprehensive breast oncology for eastern and neighboring origins.	Check reconstruction and radiation scheduling early.
Ahmedabad	INR 4,30,000-21,00,000+	USD 4,500-21,800+	Selected comprehensive cancer centers provide all major breast treatment modes.	Confirm emergency support for repeated cycles.
Pune	INR 4,50,000-22,00,000+	USD 4,700-22,900+	Several private and institutional teams manage planned multimodality breast care.	Compare surgeon and radiation campus locations.
Kochi	INR 4,20,000-20,00,000+	USD 4,400-20,800+	Selected programs support breast surgery, systemic treatment, radiation, and rehabilitation.	Regional access may reduce long-course burden.
Indore, Bhopal, Nagpur or Vizag	INR 4,00,000-18,00,000+	USD 4,200-18,700+	Defined early surgery, stable cycles, or radiation may offer value with reliable pathology and multidisciplinary review.	Complex flap reconstruction or unusual disease may need a larger referral center.

Estimate variables

What can change the final hospital cost

Stage and nodal extent

Tumor size, breast distribution, skin or chest involvement, nodes, and distant spread determine treatment intent and sequence.

Use current staging evidence.

ER, PR, HER2 and biology

Receptor pattern, grade, proliferation, and selected genomic findings alter medicine choice and duration.

Repeat uncertain results when clinically justified.

Operation and reconstruction

Conservation, mastectomy, node procedure, re-excision, implant, flap, and opposite-side work change teams and theatre time.

Request component pricing.

Systemic protocol

Drug, body-size dose, brand, cycles, growth factor, ovarian protection, and maintenance create repeated costs.

Price expected total and each checkpoint.

Radiation course

Breast or chest wall, nodal fields, boost, technique, planning, breath-hold, and fractions affect cost and stay.

Obtain the complete course.

Complications and function

Wound, seroma, infection, lymphoedema, neuropathy, cardiac effects, fertility, and rehabilitation can add ongoing care.

Plan local support.

Medical cost breakdown

Before admission, in hospital, and after discharge

Diagnostics and preparation

Core biopsy and pathology review

Histology, grade, ER, PR, HER2, Ki-67, and repeat or confirmatory testing where needed.

Preserve blocks for later tests.

Breast and axillary imaging

Diagnostic mammography, ultrasound, and selected MRI define extent and biopsy targets.

MRI is not required for every patient.

Stage and hereditary assessment

Selected CT, PET-CT or bone imaging and germline counseling or testing based on risk.

Match tests to the clinical indication.

Treatment fitness

Blood and organ tests, ECG or echo for relevant drugs, fertility counseling, and anesthesia or reconstruction review.

Baseline heart function may affect HER2 therapy.

Admission and treatment

Breast and node surgery

Surgeons, anesthesia, theatre, localization, pathology handling, room, drains, and standard consumables.

Margin and node pathology may be billed separately.

Reconstruction

Plastic-surgery team, implant or flap materials, microsurgery, monitoring, ICU or ward, and donor-site care.

Future revisions are not usually included.

Systemic day care

Named drug and dose, infusion, nursing, premedication, routine monitoring, and stated support.

Vial wastage and growth factor need clarity.

Radiation delivery

Simulation, planning, image guidance, fractions, boost, breath-hold, and review visits.

Compare the whole prescribed course.

Recovery and follow-up

Wound, drain, and shoulder care

Review, dressings, drain removal, range-of-motion exercises, and infection or seroma management.

Ask when flying is safe.

Lymphoedema prevention and treatment

Education, measurement, physiotherapy, compression, and specialist review after node treatment.

Symptoms can appear later.

Long-term medicines and monitoring

Hormone or HER2 therapy, heart or bone checks, menopausal support, and adherence review.

Budget home-country supply.

Surveillance and survivorship

Clinical follow-up, breast imaging, rehabilitation, fertility, sexual wellbeing, psychosocial support, and late-effect care.

Avoid unnecessary routine scans.

Complete journey budget

Plan beyond the hospital invoice

Patient and attendant costs should be modeled separately from the medical estimate, with flexible dates and a contingency reserve.

Treatment-phase travel

Flexible flights and transfers for surgery, radiation weeks, infusion cycles, or later reconstruction.

Sequence can change after pathology.

Visa and tissue documents

Medical visa, attendant paperwork, pathology shipment, translations, and imaging transfer.

Retain original tissue records.

Recovery accommodation

Clean lodging near the hospital with food, laundry, drain care, and accessible transport.

Radiation can require a longer stay.

Home continuation

Medicines, infusions, cardiac monitoring, radiation records, wound and lymphoedema care, and local oncology.

Confirm product compatibility.

Contingency

Re-excision, delayed wound, infection, low counts, changed cycle, drug reaction, extra stay, or flight change.

Keep funds outside the quoted plan.

Country access

Rules and practical requirements to verify

Visa, donor, fertility, medicine, licensing, and treatment-access requirements can change. Confirm current rules with the relevant authority and treating hospital.

Verify official visa details

Check current medical and attendant categories, documents, permitted stay, entries, and fees through the Government of India portal.

Plan pathology custody

Document slide and block inventory, laboratory receipt, consent, return, courier, and remaining tissue before cross-border review.

Carry medicine and implant records

Keep generic and brand drug names, doses, infusion dates, allergies, reconstruction implant card, operation note, and radiation summary.

Use urgent local care for warning signs

Fever during treatment, severe breathlessness, bleeding, confusion, chest symptoms, rapidly expanding wound swelling, or uncontrolled vomiting is urgent.

Hospital selection

Compare capability before package price

Dedicated breast team

Verify breast imaging, pathology, breast and oncoplastic surgery, medical and radiation oncology, reconstruction, genetics, and rehabilitation.

Ask who leads the sequence.

Pathology quality and tissue policy

Confirm receptor testing, HER2 resolution, genomic test handling, turnaround, tissue use, and return.

Biology determines expensive therapy.

Conservation and node expertise

Ask about localization, margin assessment, sentinel-node mapping, axillary strategy, and re-excision pathway.

Avoid generic surgery claims.

Reconstruction capability

Compare implant, oncoplastic, pedicled and free-flap options, radiation coordination, revisions, ICU, and complications.

Use a separate itemized estimate.

Systemic and radiation continuity

Check drug access, day care, cardiac monitoring, fertility discussion, radiation technology, and cross-border handover.

Long-term treatment must remain feasible.

Complete estimate

Require surgery, pathology, reconstruction, cycles, drugs, radiation, supportive care, days, exclusions, and later checkpoints.

Do not compare the operation alone.

Treating team

Specialists and support that may matter

Breast surgical oncologist

Plans conservation or mastectomy, margins, node surgery, oncoplastic options, and sequencing.

Breast pathologist and radiologist

Confirm disease type, receptor biology, local extent, biopsy targets, and response.

Medical oncologist

Selects preoperative, adjuvant, targeted, immune, hormone, or metastatic systemic treatment.

Radiation oncologist

Defines indications, fields, fractions, boost, technology, timing, and organ protection.

Plastic surgeon and rehabilitation team

Address reconstruction, symmetry, wound and donor-site recovery, shoulder movement, lymphoedema, and quality of life.

Hospital comparison guides

Compare hospitals around this exact treatment decision

Use these report-led guides to compare programme capability, clinical support, city fit, verification questions, recovery planning, and continuity after returning home.

Compare breast cancer treatment hospitals

Review pathology, staging, breast surgery, systemic treatment, radiation, reconstruction, and follow-up.

Treatment timeline

From report review to return-home follow-up

1. Pathology and imaging review

Core biopsy, receptors, breast and axillary imaging, symptoms, and prior records are verified.

2. Stage and biology decision

The team determines whether more imaging, hereditary testing, or genomic testing changes the plan.

3. Sequence and preference discussion

Surgery first, preoperative treatment, conservation, mastectomy, reconstruction, radiation, and long-term medicines are compared.

4. Phase-specific estimates

Each operation, reconstruction component, drug cycle, radiation course, test, and exclusion is priced.

5. Treatment and pathology checkpoint

Response, surgical findings, margins, nodes, and final pathology refine later therapy.

6. Local recovery and next phase

Wound, drain, shoulder, counts, medicines, radiation simulation, or next infusion are reviewed before travel.

7. Home survivorship plan

Local teams continue medicines, cardiac or bone monitoring, breast imaging, lymphoedema care, and recurrence surveillance.

Risks and edge cases

Events that can change the plan, stay, or cost

Pathology or receptor discordance

Review can change histology, grade, ER, PR, HER2, or eligibility for a planned drug.

Resolve before committing to therapy.

Positive margin or unexpected nodes

Final surgery pathology may require re-excision, axillary treatment, radiation change, or systemic escalation.

Ask how this is priced.

Reconstruction complication

Skin or flap loss, implant infection, seroma, thrombosis, or wound delay can require intervention and postpone cancer therapy.

Cancer timing remains the priority.

Systemic toxicity

Low counts, infection, neuropathy, cardiac change, immune inflammation, clot, or organ dysfunction can delay cycles.

Know emergency contacts at home and in India.

Fertility or pregnancy issue

Treatment timing and medicines can affect fertility, pregnancy, breastfeeding, and contraception.

Discuss before systemic therapy.

Fragmented long-term treatment

Unavailable drug, incompatible protocol, missing radiation data, or unclear prescribing responsibility can interrupt care after return.

Confirm handover in advance.

Destination comparison

Compare India, Turkey, and Thailand for this procedure

The most suitable destination depends on the individual case, required team, treatment availability, travel route, legal eligibility, budget, and continuity after returning home.

Procedure planning comparison across India, Turkey, and Thailand
Decision factor	India	Turkey	Thailand	How to use this
Complete pathway cost	Multiple city and hospital tiers; surgery may be comparatively accessible while prolonged targeted or immune drugs remain major costs.	Private packages may combine surgery and hospitality but medicine duration needs separate review.	International breast programs may offer integrated private services at higher non-medical cost.	Compare stage, operation, reconstruction, exact drugs, radiation, and follow-up.
Breast-team breadth	Selected centers offer oncoplastic, microsurgical, medical, radiation, genetics, and lymphoedema services.	Advanced breast and reconstruction teams cluster in major cities.	Bangkok provides broad international breast care with selected regional options.	Match capability to conservation and reconstruction goals.
Long-course care	Value cities may suit defined radiation or stable cycles when the protocol and emergency pathway are robust.	Regional proximity may reduce travel for some origins.	Hospital coordination can simplify repeated private visits.	Price attendant stay and every treatment visit.
Medicine continuity	Generic and branded availability varies; HER2, hormone, and immune plans need home supply confirmation.	Verify brand, dose, translated records, and continuation.	Confirm product and monitoring after departure.	Do not start a prolonged drug that cannot be continued safely.

Decision guidance

When India may fit and when to keep comparing

India may fit when

Pathology and stage are clear, the required breast and reconstruction team is verified, travel is safe, and later drugs or radiation remain affordable and accessible.

A major metro may fit when

Complex conservation, microsurgical reconstruction, unusual pathology, advanced disease, major comorbidity, or high-cost targeted and immune therapy is involved.

A value city may fit when

The treatment phase is defined, breast pathology and oncology are reliable, surgery or radiation capability matches the case, and emergency support is documented.

Local care may be preferable when

Treatment must start urgently, repeated travel would disrupt cycles or radiation, or wound, infusion, and emergency follow-up cannot be sustained after return.

Reports for review

Prepare a case file before requesting estimates

Send core-biopsy pathology, ER, PR, HER2 and Ki-67, original breast and axillary images, current stage evidence, previous operation or systemic records, medicines, blood and organ tests, menstrual and pregnancy status where relevant, family history, and the patient’s conservation, reconstruction, fertility, and travel priorities.

Upload medical reports

Breast diagnosis and extent

These records establish subtype, local anatomy, and stage.

Biopsy, slides and blocks

Include histology, grade, ER, PR, HER2 method and result, Ki-67, and tissue availability.

Breast and node imaging

Provide viewable mammography, ultrasound, MRI when performed, measurements, multifocality, and axillary findings.

Stage and response imaging

Share appropriately selected CT, PET-CT, bone imaging, or interval studies and formal reports.

Hereditary or genomic tests

Include germline and recurrence-assay results only when performed, with counseling and laboratory information.

Treatment and safety record

These details shape sequence, dose, surgery, and recovery.

Prior operation or drug chronology

List procedure, margins, nodes, reconstruction, every drug and dose, dates, response, and toxicity.

Current blood and organ tests

Include CBC, kidney, liver, glucose, cardiac testing when relevant, and trends during therapy.

Function and medical history

Describe shoulder, arm swelling, heart disease, clot, diabetes, smoking, fertility, menopause, and daily activity.

Goals and logistics

State breast-preservation, reconstruction, fertility, timing, attendant, home oncology, radiation, and medicine access.

Common questions

Questions about cost, travel, and follow-up

Does breast cancer treatment always start with surgery?

No. Many early cancers begin with surgery, while selected larger, node-positive, HER2-positive, or triple-negative cancers may receive systemic treatment first. Stage, biology, and multidisciplinary review determine sequence.

Is reconstruction included in a mastectomy price?

Not unless the quote names the technique, plastic surgeon, implant or flap, materials, admission, donor-site care, and revisions. Cancer surgery and reconstruction should be itemized separately.

Why do HER2-positive treatment estimates cost more?

HER2-directed medicines may continue for many cycles and can dominate the budget. The estimate should state drug, brand, dose, interval, expected duration, cardiac monitoring, and supportive costs.

Can lumpectomy be cheaper than mastectomy?

The operation may cost less, but breast conservation commonly includes radiation and can require re-excision for margins. Compare complete pathways and clinical suitability, not the first admission only.

What reports are needed for a useful estimate?

Core pathology, ER, PR, HER2, Ki-67, breast and axillary imaging, current stage evidence, previous treatment, blood tests, medical history, and the patient’s reconstruction and fertility priorities.

Can chemotherapy or targeted therapy continue at home?

Sometimes, if the same protocol and product are available, both oncology teams agree, records transfer promptly, monitoring is reliable, and emergency care is accessible.

Can a Tier 2 city manage breast cancer care?

Selected programs can manage defined surgery, radiation, or stable systemic phases when breast pathology, multidisciplinary review, pharmacy, emergency response, and escalation are verified.

How long should an international patient stay?

Surgery requires wound and pathology review; radiation can require weeks; systemic treatment follows cycles. The team should define which checkpoints need the patient physically in India.

Can treatment affect fertility or menopause?

Yes. Some surgery and systemic treatments can affect ovarian function, fertility, pregnancy timing, bone health, and menopausal symptoms. Discuss preservation and long-term care before treatment starts.

Does Virello recommend surgery or a drug?

No. The treating breast team makes clinical recommendations with the patient. Virello can organize reports and compare written pathway and cost assumptions but cannot guarantee price or outcome.

Review and sources

How this guide was prepared

Virello combined current Indian oncology charge structures and market ranges with recognized breast stage, biomarker, surgery, and radiation guidance. Costs are separated into surgery-led, combined, and high-cost subtype pathways because stage and receptor biology determine treatment more accurately than one average breast-cancer price.

This page is educational and does not diagnose breast cancer, assign stage, choose surgery or medicine, or guarantee cost or outcome. Fever during therapy, severe breathlessness, chest symptoms, bleeding, confusion, rapidly worsening wound swelling, persistent vomiting, or new neurologic symptoms requires urgent local assessment.

Related planning